Huabang Health (002004.SZ): Calzosandopa extended-release tablets obtained a drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, Huabang Health (002004.SZ) issued an announcement. Chongqing Huabang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration for cazosuandopa sustained-release tablets. Calzosandopa extended-release tablets are declared according to the 4 categories of chemicals, which is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs. The official approval of this product will further enrich the company's product pipeline layout in the field of Parkinson's disease treatment, while providing clinical patients with more high-quality medication options.